Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Bladder cancer updates from the second half of 2024
Bladder cancer updates from the second half of 2024
Prof Alison Birtle, Dr Ignacio Durán and Dr Félix Guerrero-Ramos
Sotorasib for advanced non-small cell lung cancer
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
Sotorasib for advanced non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
CaRE2 Cancer Research Link©: Social Determinants of Health on Cancer Outcomes...
Kenneth Stokes, Lynette Jones and Dr Herman Tucker
CaRE2 Cancer Research Link©: Social Determinants of Health on Cancer Outcomes in Black Populations ( Kenneth Stokes, Lynette Jones and Dr Herman Tucker )
4 Nov 2020
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Prospective validation of single mouse testing by the paediatric preclinical...
Dr Peter Houghton - Greehey Children's Cancer Institute, San Antonio, USA
Prospective validation of single mouse testing by the paediatric preclinical testing consortium ( Dr Peter Houghton - Greehey Children's Cancer Institute, San Antonio, USA )
4 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )
4 Nov 2020
The ENA virtual meeting 2020
Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
The ENA virtual meeting 2020 ( Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation
Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation ( Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
4 Nov 2020
Development of novel inhibitors of KRASG12C
Dr Kevan Shokat - University of California San Francisco, San Francisco, USA
Development of novel inhibitors of KRASG12C ( Dr Kevan Shokat - University of California San Francisco, San Francisco, USA )
4 Nov 2020
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1...
Dr Julius Strauss - National Institutes of Health, Bethseda, USA
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy ( Dr Julius Strauss - National Institutes of Health, Bethseda, USA )
4 Nov 2020
Managing multiple myeloma during the COVID-19 pandemic in Brazil
Dr Vania Hungria - Santa Casa de São Paulo, São Paulo, Brazil
Managing multiple myeloma during the COVID-19 pandemic in Brazil ( Dr Vania Hungria - Santa Casa de São Paulo, São Paulo, Brazil )
3 Nov 2020
Updates in surgical oncology from SIOG 2020
Dr Isacco Montroni - Ospedale per gli Infermi, Faenza, Italy
Updates in surgical oncology from SIOG 2020 ( Dr Isacco Montroni - Ospedale per gli Infermi, Faenza, Italy )
2 Nov 2020
Inter-laboratory concordance in clinical trials
Prof Ian Cree - International Agency for Research on Cancer
Inter-laboratory concordance in clinical trials ( Prof Ian Cree - International Agency for Research on Cancer )
2 Nov 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation